March 28, 2023
- NOT-OD-20-031 - Notice of NIH's Interest in Diversity
- PAR-21-063 - NIDCD Low Risk Clinical Trials in Communication Disorders (R01 Clinical Trial Required)
- PA-20-185 - NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)
- PAR-21-357 - Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required)
- PAR-22-060 - Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)
- PAR-21-154 - Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- PAR-21-155 - Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed)
- PAR-21-107 - NIDCD Early Career Research (ECR) Award (R21 Clinical Trial Optional)
Please note: For PAR-21-107, the PD/PI must be no more than 7-years from the date the terminal degree was received. Read the NOFO carefully for specific details and exceptions.
- PA-20-194 - NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Required)
- PA-20-195 - NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed)
- RFA-DC-23-001: NIDCD Research Opportunities for New Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)
Issued by
National Institute on Deafness and Other Communication Disorders (NIDCD)
The National Institute on Deafness and Other Communication Disorders (NIDCD) is issuing this Notice of Special Interest (NOSI) to stimulate research in areas regarding the health of women within the scope of NIDCD’s mission. NIDCD's mission is to conduct and support research and research training in the normal and disordered processes of hearing, balance, taste, smell, voice, speech, and language. As noted in the recently issued 2023–2027 NIDCD Strategic Plan (2023-2027 NIDCD Strategic Plan | NIDCD), research projects to improve the health of women covering the lifespan are encouraged across all the NIDCD mission areas. These projects may include biological studies which may incorporate anatomical, structural, hormonal, or genetic aspects, behavioral traits, societal aspects, or healthcare related activities that may benefit a women's quality of life.
Research Objective and Scope
Communication disorders can have a significant impact on women’s overall health and well-being affecting their ability to engage in daily activities, participate in society and immerse in the workforce. Because communication disorders can affect the physical, emotional, social, recreational, educational, and vocational aspects of life, women may experience health disparities due to one of any combination of these conditions which can impact quality of life. The goal of this NOSI is to stimulate research focused on the health of women within the NIDCD mission areas.
To better understand these issues and to develop effective interventions, NIDCD is seeking research applications that focus on the intersection between the health of women and their ability to hear, maintain balance, taste, smell, use of their voice, produce and understand speech and language across all ages, geographic distributions, ethnicities, race, and socioeconomic status. This may include studies that investigate the underlying causes of these health states, their impact on women’s health and well-being, and strategies for preventing, mitigating, or treating these conditions in women.
Applications submitted in response to this NOSI should be relevant to the mission of NIDCD. For example, research on hearing, balance, taste, smell, voice, speech and/or language that are appropriate to this NOSI include, but are not limited to:
- Expanding the understanding of sex differences impacting hearing loss, balance disorders, taste and smell abnormalities, voice disorders, speech, and language disorders.
- The prevalence, incidence, and natural history of hearing loss, balance disorders, taste and smell abnormalities, voice disorders, speech disorders, and language disorders in women.
- The physiological and psychological factors that contribute to the development or progression of communication disorders in women.
- The impact of communication disorders on women’s overall health and well-being.
- The development and evaluation of interventions or treatment strategies, including pharmacological, behavioral, social, surgical and technology-driven approaches, for preventing, mitigating, or treating conditions impacting women in NIDCD mission areas.
This notice applies to due dates on or after May 5, 2023 and subsequent receipt dates through May 6, 2026.
Potential applicants to this NOSI are strongly encouraged to contact Scientific/Research staff prior to submission.
Submit applications for this initiative using one of the following Notices of Funding Opportunities (NOFOs) or any reissues of these through the expiration date of this notice.
- PAR-21-063 - NIDCD Low Risk Clinical Trials in Communication Disorders (R01 Clinical Trial Required)
- PA-20-185 - NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)
- PAR-21-357 - Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required)
- PAR-22-060 - Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)
- PAR-21-154 - Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- PAR-21-155 - Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed)
- PAR-21-107 - NIDCD Early Career Research (ECR) Award (R21 Clinical Trial Optional)
- Please note: For PAR-21-107, the PD/PI must be no more than 7-years from the date the terminal degree was received. Read the NOFO carefully for specific details and exceptions.
- PA-20-194 - NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Required)
- PA-20-195 - NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed)
- RFA-DC-23-001: NIDCD Research Opportunities for New Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)
All instructions in the SF424 (R&R) Application Guide and the funding opportunity announcement used for submission must be followed, with the following additions:
- For funding consideration, applicants must include “NOT-DC-23-006” (without quotation marks) in the Agency Routing Identifier field (box 4B) of the SF424 R&R form. Applications without this information in box 4B will not be considered for this initiative.
Applications nonresponsive to terms of this NOSI will not be considered for the NOSI initiative.
Scientific/Research Contact(s)
Trinh T. Ly, MD
National Institute on Deafness and Other Communication Disorders (NIDCD)
Telephone: 301-435-4085
Email: [email protected]
Peer Review Contact(s)
Examine your eRA Commons account for review assignment and contact information (information appears two weeks after the submission due date).
Financial/Grants Management Contact(s)
Samantha Tempchin
National Institute on Deafness and Other Communication Disorders (NIDCD)
Telephone: 301-435-1404
Email: [email protected]
and Human Services (HHS)
